|
|
|
Volumn 7, Issue 16 SUPPL. OCTOBER, 2001, Pages
|
|
Modulation of hormones in the treatment of lupus
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
16ALPHA HYDROXYESTRONE;
ANDROGEN;
ANTIESTROGEN;
BROMOCRIPTINE;
DANAZOL;
DOPAMINE RECEPTOR STIMULATING AGENT;
ESTRADIOL;
ESTROGEN;
HORMONE;
HYDROXYCHLOROQUINE;
NANDROLONE;
PEPTIDE HORMONE;
PLACEBO;
PRASTERONE;
PREDNISONE;
PROLACTIN;
TAMOXIFEN;
TESTOSTERONE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DISEASE ACTIVITY;
DISEASE SEVERITY;
DRUG CONTRAINDICATION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG INHIBITION;
ENDOCRINE SYSTEM;
ESTROGEN METABOLISM;
HORMONE BLOOD LEVEL;
HORMONE RELEASE;
HORMONE SUBSTITUTION;
HUMAN;
HYPERPROLACTINEMIA;
HYPOPHYSIS;
IMMUNE SYSTEM;
MEDICAL RESEARCH;
NONHUMAN;
PRIORITY JOURNAL;
PROLACTIN BLOOD LEVEL;
PROLACTIN RELEASE;
SYSTEMIC LUPUS ERYTHEMATOSUS;
ANIMALS;
BROMOCRIPTINE;
DOPAMINE AGONISTS;
ESTROGENS;
HORMONES;
HUMANS;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
PROLACTIN;
TESTOSTERONE;
|
|
EID: 0034762088
PISSN: 10880224
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (11)
|
|
References (19)
|
